BIOXCEL THERAPEUTICS INC's ticker is BTAI and the CUSIP is 09075P105. A total of 95 filers reported holding BIOXCEL THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.94 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $10,016 | -14.9% | 330 | -18.5% | 0.00% | -25.0% |
| Q2 2021 | $11,769 | +1.0% | 405 | +50.0% | 0.00% | 0.0% |
| Q1 2021 | $11,653 | +5.1% | 270 | +12.5% | 0.00% | 0.0% |
| Q4 2020 | $11,088 | +922.9% | 240 | +860.0% | 0.00% | – |
| Q3 2020 | $1,084 | -18.2% | 25 | 0.0% | 0.00% | -100.0% |
| Q2 2020 | $1,325 | – | 25 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 315,000 | $7,040,000 | 3.41% |
| Ikarian Capital, LLC | 693,716 | $15,505,000 | 1.17% |
| EAM Global Investors LLC | 71,838 | $1,606,000 | 0.94% |
| Avidity Partners Management LP | 211,000 | $4,716,000 | 0.65% |
| MOODY ALDRICH PARTNERS LLC | 79,642 | $1,780,000 | 0.54% |
| Knoll Capital Management, LLC | 20,000 | $447,000 | 0.42% |
| EAM Investors, LLC | 55,775 | $1,247,000 | 0.39% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 299,932 | $6,703,000 | 0.22% |
| Coastal Bridge Advisors, LLC | 25,014 | $559,000 | 0.20% |
| Ikarian Capital, LLC | 103,300 | $2,309,000 | 0.17% |